Global Therapeutic Drug Monitoring Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Executive Summary
According to GRD Survey data, the global Therapeutic Drug Monitoring market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Therapeutic Drug Monitoring market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Therapeutic Drug Monitoring in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Blood Test
Urine Test
Saliva Test
Other Test
Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% revenue market share in 2019.
Market Snapshot, By Application
Hospital Labs
Private Labs
Others
Hospital labs holds an important share in terms of applications with a sales market share of over 50% in 2018.
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Thermo Fisher Scientific
Siemens Healthcare
Sanquin
Roche
Quest Diagnostics
Danaher
Bio-Rad Laboratories
BioMerieux
Becton Dickinson
Abbott
The study objectives of this report are:
To study and analyze the global Therapeutic Drug Monitoring market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Therapeutic Drug Monitoring market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Therapeutic Drug Monitoring manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Drug Monitoring market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Therapeutic Drug Monitoring submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Therapeutic Drug Monitoring are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Therapeutic Drug Monitoring Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Therapeutic Drug Monitoring Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Therapeutic Drug Monitoring
3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Application One
3.2.2 Major Buyers in Application Two
3.2.1 Major Buyers in Application Three
4 Market Segment: by Type
4.1 Therapeutic Drug Monitoring Type Introduction
4.1.1 Blood Test
4.1.2 Urine Test
4.1.3 Saliva Test
4.1.4 Other Test
4.1.5 Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% revenue market share in 2019.
4.2 Global Therapeutic Drug Monitoring Revenue by Type 2016-2021
5 Market Segment: by Application
5.1 Therapeutic Drug Monitoring Type Introduction
5.1.1 Hospital Labs
5.1.2 Private Labs
5.1.3 Others
5.1.3 Hospital labs holds an important share in terms of applications with a sales market share of over 50% in 2018.
5.2 Global Therapeutic Drug Monitoring Revenue by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Therapeutic Drug Monitoring Market by Region
6.2 North America Therapeutic Drug Monitoring Market 2016-2021
6.3 Europe Therapeutic Drug Monitoring Market 2016-2021
6.4 Asia Pacific Therapeutic Drug Monitoring Market 2016-2021
6.5 South America Therapeutic Drug Monitoring Market 2016-2021
6.6 Middle East and Africa Therapeutic Drug Monitoring Market 2016-2021
7 North America
7.1 North America Therapeutic Drug Monitoring Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Therapeutic Drug Monitoring Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Therapeutic Drug Monitoring Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Therapeutic Drug Monitoring Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Therapeutic Drug Monitoring Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
3.1 Thermo Fisher Scientific
3.1.1 Thermo Fisher Scientific Company Information
3.1.2 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.1.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.1.4 Thermo Fisher Scientific Key Development
3.2 Siemens Healthcare
3.2.1 Siemens Healthcare Company Information
3.2.2 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.2.3 Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.2.4 Siemens Healthcare Key Development
3.3 Sanquin
3.3.1 Sanquin Company Information
3.3.2 Sanquin Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.3.3 Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.3.4 Sanquin Key Development
3.4 Roche
3.4.1 Roche Company Information
3.4.2 Roche Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.4.3 Roche Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.4.4 Roche Key Development
3.5 Quest Diagnostics
3.5.1 Quest Diagnostics Company Information
3.5.2 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.5.3 Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.5.4 Quest Diagnostics Key Development
3.6 Danaher
3.6.1 Danaher Company Information
3.6.2 Danaher Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.6.3 Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.6.4 Danaher Key Development
3.7 Bio-Rad Laboratories
3.7.1 Bio-Rad Laboratories Company Information
3.7.2 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.7.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.7.4 Danaher Key Development
3.9 Becton Dickinson
3.9.1 Becton Dickinson Company Information
3.9.2 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.9.3 Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.9.4 Becton Dickinson Key Development
3.8 BioMerieux
3.8.1 BioMerieux Company Information
3.8.2 BioMerieux Therapeutic Drug Monitoring Product Portfolio, Specification and Application
3.8.3 BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
3.8.4 BioMerieux Key Development
13 Global Therapeutic Drug Monitoring Market Forecast by Region by Type and by Application
13.1 Global Therapeutic Drug Monitoring Revenue Forecast 2022-2027
13.2 Global Therapeutic Drug Monitoring Forecast by Regions
13.3 Global Therapeutic Drug Monitoring Forecast by Type
13.4 Global Therapeutic Drug Monitoring Forecast by Application
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Therapeutic Drug Monitoring Production Specifications
Table 2: Drivers in Therapeutic Drug Monitoring Market
Table 3: Restraints Therapeutic Drug Monitoring Market
Table 4: Opportunity in Therapeutic Drug Monitoring Market
Table 5: Comparion of Alternative and Therapeutic Drug Monitoring
Table 6: Therapeutic Drug Monitoring Raw Materials Key Suppliers List
Table 7: Therapeutic Drug Monitoring Distributors List
Table 8: Therapeutic Drug Monitoring Major Buyers in Application One
Table 9: Therapeutic Drug Monitoring Major Buyers in Application Two
Table 10: Therapeutic Drug Monitoring Major Buyers in Application Three
Table 11: Global Therapeutic Drug Monitoring Revenue (Million USD) by Type 2016-2021
Table 12: Global Therapeutic Drug Monitoring Revenue Market Share by Type 2016-2021
Table 18: Global Therapeutic Drug Monitoring Revenue (Million USD) by Application 2016-2021
Table 19: Global Therapeutic Drug Monitoring Revenue Market Share by Application 2016-2021
Table 20: Global Therapeutic Drug Monitoring Revenue (Million USD) by Region 2016-2021
Table 21: Global Therapeutic Drug Monitoring Revenue Market Share by Region 2016-2021
Table 22: North America Therapeutic Drug Monitoring Revenue (Million USD) by Country 2016-2021
Table 23: North America Therapeutic Drug Monitoring Revenue Market Share by Country 2016-2021)
Table 24: Europe Therapeutic Drug Monitoring Revenue (Million USD) by Country 2016-2021
Table 25: Europe Therapeutic Drug Monitoring Revenue Market Share by Country 2016-2021)
Table 26: Asia Pacific Therapeutic Drug Monitoring Revenue (Million USD) by Country 2016-2021
Table 27: Asia Pacific Therapeutic Drug Monitoring Revenue Market Share by Country 2016-2021)
Table 28: South America Therapeutic Drug Monitoring Revenue (Million USD) by Country 2016-2021
Table 29: South America Therapeutic Drug Monitoring Revenue Market Share by Country 2016-2021)
Table 30: Middle East and Africa Therapeutic Drug Monitoring Revenue (Million USD) by Country 2016-2021
Table 31: Middle East and Africa Therapeutic Drug Monitoring Revenue Market Share by Country 2016-2021)
Table 32 Thermo Fisher Scientific Company Information
Table 33 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 34 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 35 Siemens Healthcare Company Information
Table 36 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 37 Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 38 Sanquin Company Information
Table 39 Sanquin Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 40 Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 41 Roche Company Information
Table 42 Roche Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 43 Roche Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 44 Quest Diagnostics Company Information
Table 45 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 46 Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 47 Danaher Company Information
Table 48 Danaher Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 49 Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 50 Bio-Rad Laboratories Company Information
Table 51 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 52 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 53 BioMerieux Company Information
Table 54 BioMerieux Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 55 BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 56 Becton Dickinson Company Information
Table 57 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio, Specification and Application
Table 58 Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (2019-2021)
Table 59: Global Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Region (2022-2027)
Table 60: Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Region (2022-2027)
Table 61: Global Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Type (2022-2027)
Table 62: Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Type (2022-2027)
Table 63: Global Therapeutic Drug Monitoring Revenue (Million USD) Forecast by Application (2022-2027)
Table 64: Global Therapeutic Drug Monitoring Revenue Market Share Forecast by Application (2022-2027)
Tables and Figures
List of Figures
Figure 1: Therapeutic Drug Monitoring Picture
Figure 2: Global Therapeutic Drug Monitoring Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Therapeutic Drug Monitoring Industry Life Cycle
Figure 5: Product Picture of Blood Test
Figure 6: Product Picture of Urine Test
Figure 9: Global Therapeutic Drug Monitoring Revenue Market Share by Type, 2020
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets